Trials / Unknown
UnknownNCT01198808
Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker
Prospective Characterization of Tumor-specific T-cell Immunity in Muscle-invasive Bladder Cancer and Its Correlation With Clinical Parameters
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Bladder cancer is generally susceptible to immunotherapeutic measures. The investigators will characterize 40 patients with muscle-invasive bladder cancer regarding the existence and frequency of tumorspecific T-cells and regulatory T cells. The found data will be correlated to clinical data such as the cancer-specific survival and the response to chemotherapy. It is hypothesized that those patients with a high number of Tregs and no tumor-specific T-cells have a worse prognosis.
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2011-12-01
- First posted
- 2010-09-10
- Last updated
- 2012-01-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01198808. Inclusion in this directory is not an endorsement.